Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,586 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Active, Not Recruiting

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

NCT04152499

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • Los Angeles Hematology Oncology Medical Group Glendale, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • START MidWest Grand Rapids, Michigan, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

Endometrial Carcinoma: Comparison of Surgical Approaches (Laparoscopy vs Laparotomy)

NCT06790004

Conditions
Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Azienda USL IRCCS di Reggio Emilia Reggio Emilia, RE, Italy
  • IRCCS - AOU Bologna Bologna, Italy
  • Policlinico Sant'Orsola - Malpighi Bologna, Italy
  • Azienda Ospedaliera- Universitaria Arcispedale Sant'Anna Ferrara Ferrara, Italy
View Trial Details
Active, Not Recruiting

PF-07104091 as a Single Agent and in Combination Therapy

NCT04553133

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +27 more
Locations
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Clive, Iowa, United States
  • Des Moines Oncology Research Association Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

NCT05173987

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • HonorHealth-USOR HonorHealth ( Site 8000) Phoenix, Arizona, United States
  • Moores Cancer Center ( Site 0037) La Jolla, California, United States
  • Kaiser Permanente Riverside Medical Center ( Site 0045) Riverside, California, United States
  • Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0013) New Haven, Connecticut, United States
View all 194 locations
View Trial Details
Active, Not Recruiting

Cisplatin+Pembrolizumab+RT in Vulvar Cancer

NCT04430699

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

NCT03393884

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Mitchell Cancer Institute (University of South Alabama) Mobile, Alabama, United States
  • Gynecologic Oncology Associates (Hoag Hospital) Newport Beach, California, United States
  • Innovative Clinical Research Whittier, California, United States
View all 21 locations
View Trial Details

Related conditions